Description
This product is a recombinant monoclonal antibody 2D03 that recognizes MDA-ApoB100. 2D03 is a human antibody that binds oxidised LDL that is useful for the treatment study of atherosclerosis.
Target
MDA-ApoB100
Target Alias Names
MDA-ApoB100, Malondialdehyde (MDA)-modified apoB-100 peptide
Isotype/Mimetic
Human IgG1
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression